ATC
PBYI icon

Adirondack Trust Company’s Puma Biotechnology PBYI Stock Holding History

Adirondack Trust Company’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30
Closed -$1K – 350
2016
Q4 		$1K Hold
30
– – ﹤0.01% 318
2016
Q3 		$2K Hold
30
– – ﹤0.01% 317
2016
Q2 		$1K Hold
30
– – ﹤0.01% 383
2016
Q1 		$1K Hold
30
– – ﹤0.01% 364
2015
Q4 		$1K Buy
+30
New +$2.35K ﹤0.01% 347

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Adirondack Trust Company's PBYI Position: Q1 2017 in Review

Adirondack Trust Company sold out of Puma Biotechnology (PBYI) in Q1 2017, closing a stake of 30 shares — an estimated $1K sold.

Adirondack Trust Company first reported a position in PBYI in Q4 2015 and held it in 5 quarters. The position peaked at $2K in Q3 2016. 136 funds tracked by Wall St. Rank hold PBYI as of Q1 2017.

  • Adirondack Trust Company reported no remaining Puma Biotechnology position as of Q1 2017 after selling out during the quarter.
  • Adirondack Trust Company sold 30 Puma Biotechnology shares in Q1 2017, an estimated $1K.
  • Adirondack Trust Company first reported a position in Puma Biotechnology in Q4 2015 and held it in 5 quarters.
  • Adirondack Trust Company's Puma Biotechnology position peaked at $2K in Q3 2016.
  • 136 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2017.

Based on Adirondack Trust Company's 13F filing for Q1 2017, filed 12 Apr 2017.